China Focus @ europe

Hamburg

Nov 10, 2019
Hamburg, Germany




ABOUT CHINA FOCUS @EUROPE

China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and medtech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.

China Focus @EUROPE Hamburg is designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.

Who should attend

  • Investors (VC, PE, investment bank, etc.)
  • Life science innovators and entrepreneurs
  • Biotech & big pharma
  • Medtech (device and diagnostics) manufacturers and distributors
  • Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
  • Healthcare providers

Main topics

  • Cross-border investment: money from the East and the West
  • Innovations going to China: regulation, market access, manufacturing and distribution
  • Chinese innovations going west: partnership for capital and market access in the U.S.

 

What you can get

  • Learn about Chinese life science and healthcare industry
  • Hear about the latest Chinese regulatory reforms and implications
  • Meet with the decision makers in the industry
  • Initiate business conversations that otherwise difficult to start

 

ABOUT CHINA FOCUS @EUROPE

China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and medtech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.

China Focus @EUROPE Hamburg is designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.

 

Who should attend

  • Investors (VC, PE, investment bank, etc.)
  • Life science innovators and entrepreneurs
  • Biotech & big pharma
  • Medtech (device and diagnostics) manufacturers and distributors
  • Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
  • Healthcare providers

Main topics

  • Cross-border investment: money from the East and the West
  • Innovations going to China: regulation, market access, manufacturing and distribution
  • Chinese innovations going west: partnership for capital and market access in the U.S.

 

What you can get

  • Learn about Chinese life science and healthcare industry
  • Hear about the latest Chinese regulatory reforms and implications
  • Meet with the decision makers in the industry
  • Initiate business conversations that otherwise difficult to start

 

ATTENDEE DEMOGRAPHICS
at Previous China Focus Events

Attendees

Chinese Companies and Investors

%

Executive Level Attendees

One-to-one meetings

InvestoRs
Qualified investors can request complimentary registration

MEDIA  REGISTRATION

Member of the press can request for a complimentary regisitration

Download Sample Attendee List from past China Focus events

Download Program from past China Focus events
INVITED SPEAKERS

Katherine Andersen

Head of U.S. Life Science & Healthcare Relationship Banking
Silicon Valley Bank

Kim Nearing

Managing Director
Cedrus Group

Alexander Gaffney

Sr. Manager
PwC Health Research Institute

Gurkeerat Singh

VP Emerging Technology and Innovation
Lilly Research Labs

Ping Cao

VP Business Development
Henlius Biotech

Brad Loncar

CEO
Loncar Investments

Daniel Chai

Managing Partner
Turret Capital

Tim Xiao

Principal
Delos Capital

Andrew Nerlinger

Venture Partner
Bill Wood Ventures

Lily Zou

CEO
Fosun Pharma USA

Mark Tang

Managing Director
Good Health Capital


Bernice Ma

Assc Principal
Evolution Road LLC

Michael Song

Sr. Manager
MedImmune

Bob Ai

Managing Director
Solebury Trout

Martin Dueñas

Founder & CEO
OniX

Danhui Wang

Managing Partner
Remedeca Partners LLC

Greg Caressi

SVP, Transformational Health

Foster & Sullivan

Christian Soschner

CEO

CS Life Science Invest

Wendy Pan

Partner

Sidley Austin LLP

Dan Zhang

CEO

Fountain Medical Development

Sean Fu

President

Luye Boston R&D LLC

Weimin Tang

Head of Global business and Executive VP

I-Mab Biopharma

Tom Du

Medical Partner

Shenzhen Share Capital

Andy Li

President and CEO

BioSense Suzhou Global

Herwig Janssen

VP, Licensing & Acquisitions Emerging Markets

Janssen Pharmaceutica

Cynthia Cai

Senior Advisor

Northern Light Venture Capital

Emmanuel Fobum

Global commercial strategy and Digital Innovation Leader

Johnson & Johnson

Alan Jiang

Chief Strategy Officer

XtalPi

REGISTRATION

Participating Companies

 CONTACT US

15 + 5 =

Registration, Sponsorship and Collaboration (China)

Youwen (Allen) Dai

youwen.dai@mybiogate.com

Registration, Sponsorship and Collaboration (U.S. and Europe)

Xinxin Li

Xinxin.li@mybiogate.com
Speaker, Group Delegation and Presenting Companies

Han Yan

han.yan@mybiogate.com

 

VENUE & ACCOMMODATION

 

Address:

Boston Convention Center 415 Summer St, Boston, MA 02210

Phone: 617-954-2000
Fax: 617-954-2299